• Markets
  • icon
  • Companies
PEB · ASX

Pacific Edge Limited (ASX:PEB)

AU$0.09

 0.005 (5.882%)
ASX:Live
21/05/2024 12:03:33 PM
Recent Earnings downgrade HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

PEB Overview

PEB Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Weak

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About PEB

Website

N/A

Telephone

Address

Description

Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. It operates in the Commercial and Research segments. The Commercial segment involves the sales, marketing, laboratory, and support to run the commercial businesses worldwide. The Research segment engages in the research and development of diagnostic and prognostic products for human cancer. The company was founded on February 27, 2001 and is headquartered in Dunedin, New Zealand.

PEB Price Chart

Key Stats

Market Cap

AU$72.91M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.07 - 0.38

Trade Value (12mth)

AU$2,453.00

1 week

6.25%

1 month

8.97%

YTD

-22.73%

1 year

-77.63%

All time high

1.6050000190734863

Key Fundamentals

EPS 3 yr Growth

-0.700%

EBITDA Margin

-150.60%

Operating Cashflow

-$24m

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

-34.90

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

811m

HALO Sector

Next Company Report Date

21-May-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

PEB Announcements

Latest Announcements

Date Announcements

21 May 24

Cash Burn Slows Coverage Catalysts in Focus

×

Cash Burn Slows Coverage Catalysts in Focus

01 May 24

Pacific Edge Full Year Result to be Announced 21 May 2024

×

Pacific Edge Full Year Result to be Announced 21 May 2024

01 May 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

01 May 24

Becoming a substantial holder

×

Becoming a substantial holder

30 April 24

Clinical Utility of Cxbladder to Headline at AUA 2024

×

Clinical Utility of Cxbladder to Headline at AUA 2024

09 April 24

Quarterly Update - Cxbladder Test Volumes Steady in Q4 24

×

Quarterly Update - Cxbladder Test Volumes Steady in Q4 24

14 March 24

Pacific Edge Directors Give Notice of Retirement

×

Pacific Edge Directors Give Notice of Retirement

22 January 24

Quarterly Update - Test Volumes Fall Following Restructure

×

Quarterly Update - Test Volumes Fall Following Restructure

22 January 24

Cxbladder Test Volumes Correction

×

Cxbladder Test Volumes Correction

15 December 23

Application for quotation of securities - PEB

×

Application for quotation of securities - PEB

05 December 23

Change in substantial holding

×

Change in substantial holding

23 November 23

Financial Results for the Half Year to 30 September 2023

×

Financial Results for the Half Year to 30 September 2023

15 November 23

Kaiser Permanente EMR Integration goes live

×

Kaiser Permanente EMR Integration goes live

25 October 23

NZX - Capital Change Notice

×

NZX - Capital Change Notice

25 October 23

NZX - D&O Disclosures - P Meintjes & G Gibson - 25 Oct 23

×

NZX - D&O Disclosures - P Meintjes & G Gibson - 25 Oct 23

25 October 23

Notification regarding unquoted securities - PEB

×

Notification regarding unquoted securities - PEB

19 October 23

Interim Financial Result to be Announced 23 November 2023

×

Interim Financial Result to be Announced 23 November 2023

16 October 23

Notification of cessation of securities - PEB

×

Notification of cessation of securities - PEB

11 October 23

Quarterly Update - Q2 24 Cxbladder Test Volumes Resilient

×

Quarterly Update - Q2 24 Cxbladder Test Volumes Resilient

02 October 23

FDA Signals Intent to Regulate Lab Developed Tests

×

FDA Signals Intent to Regulate Lab Developed Tests

19 September 23

NZX - D&O Disclosures - A Barclay & A Masfen

×

NZX - D&O Disclosures - A Barclay & A Masfen

11 September 23

Pacific Edge Releases Submissions on Medicare LCD

×

Pacific Edge Releases Submissions on Medicare LCD

08 September 23

Application for quotation of securities - PEB

×

Application for quotation of securities - PEB

08 September 23

NZX - D&O Disclosures - P Meintjes & G Gibson

×

NZX - D&O Disclosures - P Meintjes & G Gibson

08 August 23

NZX - D&O Disclosure - Bryan Williams

×

NZX - D&O Disclosure - Bryan Williams

PEB Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.02 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.02 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 39.8 -30.6 -26.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.02 -0.03 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.02 -0.02 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 36.2 -36.3 -48.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock -1.9 -2.5 N/A Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 N/A Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.03 0.12 0.09 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.03 0.12 0.09 Lock Lock Lock
     Growth % Lock Lock Lock Lock 56.6 291.8 -24.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 714 768 N/A Lock Lock Lock
Basic m Lock Lock Lock Lock 714 768 N/A Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 7 11 18 Lock Lock Lock
     Growth % Lock Lock Lock Lock 73.2 50.0 69.2 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 18 25 49 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 2 4 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 250.0 147.4 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 24.2 39.9 N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 76 60 N/A Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -15 -20 -27 Lock Lock Lock
     Growth % Lock Lock Lock Lock 16.3 -34.5 -40.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -201.9 -181.0 -150.6 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -16 -21 -29 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.5 -32.4 -37.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -219.7 -194.0 -157.8 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -14 -20 N/A Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -1 N/A Lock Lock Lock
Net Income $m Lock Lock Lock Lock -13 -19 -25 Lock Lock Lock
     Growth % Lock Lock Lock Lock 26.0 -40.4 -34.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -184.7 -172.9 -137.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -13 -17 -24 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 1 2 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -6 -49 21 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 21 95 -1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -13 -17 -21 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.3 -33.2 -24.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.8 -1.6 -1.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 21 98 N/A Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 29 107 84 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 2 1 N/A Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -19 -96 -72 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 6 6 N/A Lock Lock Lock
Equity $m Lock Lock Lock Lock 23 100 77 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 25 101 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 69.3 309.2 N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -46.3 -17.5 -29.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -57.5 -18.6 -32.6 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -76.5 -32.7 N/A Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -67.5 -29.6 N/A Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -64.4 -26.3 N/A Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -398.7 -900.7 -34.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.3 4.9 2.6 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -80.7 -95.5 -93.6 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 6.4 18.4 N/A Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 6.2 18.3 N/A Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 84.6 94.4 N/A Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -320.9 -295.0 -283.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.4 3.4 N/A Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 7.3 7.8 N/A Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.3 0.1 N/A Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 10.5 16.4 N/A Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.3 0.1 0.2 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.3 0.1 0.2 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -197.1 -184.9 N/A Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -49.4 -18.7 N/A Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -46.3 -17.5 -29.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -57.5 -18.6 -32.6 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 N/A Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -57.5 -18.6 N/A Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 50.1 46.7 N/A Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 82.7 107.4 N/A Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 132.8 154.1 N/A Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 48.0 68.6 N/A Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 84.8 85.5 N/A Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PEB Shortsell

Frequently Asked Questions

The current share price of Pacific Edge Limited (PEB:ASX) is AU$0.09.
The 52-week high share price for Pacific Edge Limited (PEB:ASX) is AU$0.38.
The 52-week low share price for Pacific Edge Limited (PEB:ASX)? is AU$0.07.
Pacific Edge Limited (PEB:ASX) does not pay a dividend.
Pacific Edge Limited (PEB:ASX) does not pay a dividend.
Pacific Edge Limited (PEB:ASX) has a franking level of 0.0%.
Pacific Edge Limited (PEB:ASX) is classified in the Healthcare.
The current P/E ratio for Pacific Edge Limited (PEB:ASX) is .